![]()
This weekend’s selections from Life Science Leader make the case that efficiency — in terms of speed, cost, and workforce effectiveness — is tantamount to innovation, in every sense of the word. For example, the changing economics of biotech, coupled with the rise of machine learning and regulatory complexity, makes drug repurposing an innovative strategy for capital-efficient drug development.
On workforce, Sanofi’s Wanda Shoer explains how strong relationships drive performance: conversations move faster, decisions stick, and teams deliver. For company leaders, building trust and forging meaningful connections will distinguish the next generation of leaders.
On the Business of Biotech, Jeff Jonas, CEO at recently launched Tortugas Neuroscience, talks about selecting derisked drug candidates for in-licensing and development, and why pragmatism in developing new CNS therapies is a key ingredient for success.
Check out a curated selection from our partners, below, and thanks as always for reading.
Ben Comer
Chief Editor, Life Science Leader
This weekend’s selections from Life Science Leader make the case that efficiency — in terms of speed, cost, and workforce effectiveness — is tantamount to innovation, in every sense of the word. For example, the 
